Trial Profile
Clinical Trials Insight: 700048846
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 16 Sep 2009
Price :
$35
*
At a glance
- Drugs INCB 3284 (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Incyte Corporation
- 16 Sep 2009 New trial record.